
The COVID-19 pandemic has highlighted the importance of biosafety in the biomedical sciences. While it is often assumed that biosafety is purely technical matter that has little to do with philosophy or the humanities, biosafety raises important ethical issues that have not been adequately examined in the scientific or bioethics literature. This article reviews some pivotal events in the history of biosafety and biosecurity and explores three different biosafety topics that generate significant ethical concerns, i.e., risk assessment, risk management, and risk distribution. The article also discusses the role of democratic governance in the oversight of biosafety and offers some suggestions for incorporating bioethics into biosafety practice, education, and policy.
Risk Management, SARS-CoV-2, COVID-19, Bioethics, Containment of Biohazards, Risk Assessment, Security Measures, Philosophy, Ethics and Political Philosophy, Humans, Original Article, Arts and Humanities, Bioethical Issues, Pandemics
Risk Management, SARS-CoV-2, COVID-19, Bioethics, Containment of Biohazards, Risk Assessment, Security Measures, Philosophy, Ethics and Political Philosophy, Humans, Original Article, Arts and Humanities, Bioethical Issues, Pandemics
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 10 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
